177 related articles for article (PubMed ID: 15372086)
1. Pharmacogenetics and drug development: the path to safer and more effective drugs.
Roses AD
Nat Rev Genet; 2004 Sep; 5(9):645-56. PubMed ID: 15372086
[TBL] [Abstract][Full Text] [Related]
2. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in drug discovery and development: a translational perspective.
Roses AD
Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
Roses AD
Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development.
McCarthy LC; Davies KJ; Campbell DA
Pharmacogenomics; 2002 Jul; 3(4):493-506. PubMed ID: 12164773
[TBL] [Abstract][Full Text] [Related]
7. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
Kramer JA; Sagartz JE; Morris DL
Nat Rev Drug Discov; 2007 Aug; 6(8):636-49. PubMed ID: 17643090
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
9. In silico prediction of clinical efficacy.
Michelson S; Sehgal A; Friedrich C
Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
[TBL] [Abstract][Full Text] [Related]
10. The variation of response to pharmacotherapy: pharmacogenetics--a new perspective to 'the right drug for the right person'.
Nicol MJ
Medsurg Nurs; 2003 Aug; 12(4):242-9. PubMed ID: 14515604
[TBL] [Abstract][Full Text] [Related]
11. Protein therapeutics: new applications for pharmacogenetics.
Krejsa C; Rogge M; Sadee W
Nat Rev Drug Discov; 2006 Jun; 5(6):507-21. PubMed ID: 16763661
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies.
Anglicheau D; Legendre C; Thervet E
Transplant Proc; 2007 Sep; 39(7):2142-4. PubMed ID: 17889118
[TBL] [Abstract][Full Text] [Related]
13. Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond.
Leeder JS
Drug Discov Today; 2004 Jul; 9(13):567-73. PubMed ID: 15203092
[TBL] [Abstract][Full Text] [Related]
14. A clinical development paradigm for cancer vaccines and related biologics.
Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
[TBL] [Abstract][Full Text] [Related]
15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm.
Manunta P; Bianchi G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S30-5. PubMed ID: 16565244
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenetics: towards personalized medicine].
Gurwitz D; Rehavi M
Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
[TBL] [Abstract][Full Text] [Related]
20. How molecular profiling could revolutionize drug discovery.
Stoughton RB; Friend SH
Nat Rev Drug Discov; 2005 Apr; 4(4):345-50. PubMed ID: 15789121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
